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Abstract  Psychiatric  neurosurgery  or  psychosurgery  remains  as  an  alternative  for  treatment
of psychiatric  disorders.  However,  its  historical  antecedents,  the  vulnerable  speciﬁc  condition
of psychiatric  patients,  the  high  cost  of  instrumentation  and  the  ethic  dilemma  about  the
autonomy  of  subjects  whose  are  candidates  to  this  kind  of  procedures  condition  to  get  a  inter-
disciplinary  and  specialized  staff  and  at  less  supervision  for  ethic  local  committee.  There  are
ablative or  deep  brain  stimulation  procedures  accepted  as  compassionate  or  investigational
use. Into  systematic  review  four  International  Ethic  Guides  are  accepted  for  the  indication,  the
implantation  and  the  follow  up  of  these  treatments.  24  bioethics  essays  were  found  them  and
9 ethics  speciﬁc  dilemmas  were  published.  Expectancy  and  development  of  this  medical  issue
are inherent  to  ﬁnancial  or  biotechnological  aspects,  consequently  is  important  to  promote  a
scientiﬁc and  philosophical  discussion.
© 2015  Sociedad  Médica  del  Hospital  General  de  México.  Published  by  Masson  Doyma  México
S.A. All  rights  reserved.
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Resumen  La  neurocirugía  psiquiátrica  ó  psicocirugía  continúa  siendo  una  alternativa  de
tratamiento  para  las  enfermedades  psiquiátricas.  Sin  embargo,  sus  antecedentes  históricos,  elneurocirugía
estereotáctica
estar dirigida  a  una  población  vulnerable,  los  altos  costos  de  instrumentación  y  el  dilema  sobre
la autonomía  del  sujeto  a  decidir  sobre  este  tipo  de  cirugía,  condicionan  a  que  estos  casos  sean
abordados por  equipos  interdisciplinarios,  altamente  especializados  y  al  menos  bajo  la  super-
visión del  Comité  de  Etica  de  la  institución  donde  se  realicen.  Existen  procedimientos  ablativos∗ Corresponding author at: Reforma 30 casa 1, Col. Tizapán-San Ángel, México, D.F. CP 01090, Mexico. Tel.: +52 55 51353645;
fax: +52 5551353630.
E-mail address: ﬁacrojimenez@yahoo.com (F. Jiménez-Ponce).
http://dx.doi.org/10.1016/j.hgmx.2015.04.001
0185-1063/© 2015 Sociedad Médica del Hospital General de México. Published by Masson Doyma México S.A. All rights reserved.
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y  por  estimulación  eléctrica  cerebral  profunda,  los  primeros  aceptados  como  tratamiento  de  uso
compasivo  y  los  segundos  se  encuentran  en  fase  de  investigación.  En  la  revisisón  sistemática
existen 4  guías  éticas  internacionales  aceptadas  respecto  a  la  indicación,  la  aplicación  y  el
seguimiento  de  estos  tratamientos.  24  ensayos  éticos  fueron  encontrados  y 9  dilemas  éticos
fueron publicados.  Las  expectativas  y  el  desarrollo  de  esta  rama  médica  están  inherentemente
ligadas  a  la  aplicación  tecnológica,  así  como  a  los  aspectos  ﬁnancieros,  por  lo  que  es  importante
desarrollar  una  discusión  cientíﬁca  y  ﬁlosóﬁca  del  tema.
© 2015  Sociedad  Médica  del  Hospital  General  de  México.  Publicado  por  Masson  Doyma  México
S.A. Todos  los  derechos  reservados.
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eurosurgery  has  been  applied  as  a  treatment  to  solve
sychiatric  disorders  since  the  beginning  of  the  past  cen-
ury.  In  its  origins,  this  chapter  of  neurological  surgery  was
enominated  as  Psychosurgery, today  this  term  has  been
eplaced  by  Psychiatric  Neurosurgery  or  Neurosurgery  for
ental  Disorders;  however,  they  still  handle  differently.  Why
s  neurosurgery  considered  as  an  alternative  in  the  treat-
ent  of  mental  disorders?  Fundamentally  because  of  four
easons:  The  high  prevalence  of  psychiatric  diseases  and
heir  social  repercussions,1--5,8 the  existence  of  a  group  of
atients  refractory  or  hard  to  control  with  conventional
ethods  whether  adjuvant  pharmacologic  or  therapeutic
physical  or  psycodynamical),1,6--13 the  abundance  of  infor-
ation  regarding  the  physiopathologic  brain  substrate  of
ental  disorders  and  the  remarkable  technological  devel-
pment  that  has  transformed  neurosurgery  in  a  safer  and
ore  precise  speciality.  However,  neurosurgery  for  mental
isorders  must  be  revised  from  the  ethical  and  moral  per-
pective.  In  this  essay  we  will  evaluate  some  ethical  and
egal  considerations  regarding  the  use  of  psychiatric  neuro-
urgery.
istorical background
sychosurgery  was  deﬁned  by  the  World  Health  Organiza-
ion  as:  ‘‘The  selective  surgical  resection  or  destruction
f  the  neural  pathways  or  normal  brain  tissue,  in  order  to
odify  the  behaviour’’.14 Neurosurgery  for  the  treatment
f  psychiatric  diseases  might  be  one  of  the  most  contro-
erted  scientiﬁc  activities  of  the  twentieth  century.  In  the
eginning  of  humanity,  trephine  (based  in  mystical  and  mag-
cal  aspect  rather  than  scientiﬁc)  was  the  ﬁrst  attempt  of
urgical  treatment  for  psychiatric  disorders.  Later  on,  in
he  anecdotic  case  of  Phineas  Cage,  clinically  described
y  John  Harlow  in  1860,  demonstrated  that  lesions  of  the
rontal  structures  produced  disinhibition  of  social  learned
onducts.15 Because  of  the  absence  of  psychopharmaco-
ogical  treatments,  in  1888,  Gottlieb  Burckhardt  a  Swiss
sychiatrist  performed  the  ﬁrst  surgical  procedures  in  psy-
hiatric  patients  with  the  anatomic  and  physiologic  theories
f  that  time.  Burckhardt  treated  patients  with  behaviour
lterations,  ‘‘eliminating  or  diminishing’’  the  areas  of
rain  with  pathologic  behaviour.  On  December  29  of  1888,
L
d
a
Pe  performed  the  ﬁrst  topectomy  and  in  1891  published
is  experience  with  six  patients  described  as  demented
nd  aggressive,  mentioning  three  important  successes,  two
artial  results  and  a  failure  that  led  to  the  patients’
eath.16
At  the  start  of  the  twentieth  century,  the  psychiatric
ffects  induced  by  injuries  in  the  frontal  lobes  on  wounded
oldiers  of  the  First  World  War  revealed  new  information.
n  1935  Fulton  and  Jacobsen,  presented,  in  the  Second
orld  Congress  of  Neurology  in  London,  their  works  per-
ormed  on  chimpanzees,  detailing  the  changes  on  behaviour
fter  frontal  lobectomy.  These  experimental  ﬁndings  on
on-human  primates  encouraged  the  possibility  to  inﬂu-
nce,  via  surgical  procedures,  the  control  of  psychiatric
isorders.17
Thus,  the  series  of  events  that  led  to  the  massive  devel-
pment  and  use  of  psychiatric  neurosurgery,  during  the
fties,  cannot  be  appreciated  without  the  comprehension
f  the  political  and  social  environment  that  surrounded
he  psychiatric  disease  at  the  start  of  the  century.  Psy-
hiatrics  and  neurologists  were  the  responsible  for  taking
are  of  these  patients.  The  number  of  psychiatric  patients
ncremented  according  to  the  population  growth  and  these
atients  were  secluded  on  mental  institutions  and  asy-
ums.  It  must  be  noted  that  the  debate  between  Sigmund
reud  against  the  functional  approach  that  Emil  Kraeplin
resented,  regarding  mental  disorders,  induced  psychia-
rists  to  become  independent  from  the  medical  branch,
hich  explains  why  neurologists  involved  themselves  more
n  the  diagnosis  and  treatment  of  patients  with  mental
iseases.  In  fact,  neurologists  rather  than  psychiatrists
ere  the  ones  who  became  the  strongest  supporters  of
sychosurgery,  given  that,  generally,  the  patients  from
hat  time  received  years  of  psychotherapeutic  treatment
nd  ‘‘somatic  therapies’’  (such  as  induced  coma,  by
nsulin  or  metrazol,  and  electroconvulsive  therapy),  with-
ut  achieving  the  adequate  therapeutic  effects  nor  social
eadjustment.13
Properly  speaking,  it  was  Egas  Moniz  who  ‘‘started’’  psy-
hosurgery  on  humans  when  he  proposed  to  the  scientiﬁc
ommunity  the  surgical  interruption  of  the  front-thalamic
ract  a  cross  of  bifrontal  burr  holes.  Egas  Moniz  and  Almeida
ima  performed  more  than  100  prefrontal  leucotomies  and
espite  their  data  never  being  systematized  nor  having
ny  clinical  follow  up,  in  1949  he  received  the  Nobel
rize  in  Physiology  and  Medicine  for  his  work  ‘‘Prefrontal
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Leucotomy’’.18,19 These  works  encouraged  American  neu-
ropsychiatrist  Walter  Freeman  together  with  neurosurgeon
James  Watts  to  ‘‘optimize’’  the  original  procedure  from
Moniz-Lima  and  instead  of  performing  frontal  trepans  to
approach  the  front-thalamic  tract,  they  would  apply  an
alternate  approach  by  supraorbital  via,  denominating  it
‘‘frontal  lobotomy’’  applying  an  surgical  instrument  similar
to  ‘‘ice  pike’’.  Unfortunately,  this  procedure  was  massively
applied,  in  the  United  States  and  around  the  world,  for  any
kind  of  mental  illness,  without  achieving  speciﬁc  beneﬁcial
results,  so  in  1955  more  than  50,000  surgeries  had  been  real-
ized.  Psychosurgery  was  then  considered  as  a  set  of  highly
invasive  surgical  procedures.  Frontal  and  temporal  lobec-
tomies  were  stigmatized  by  their  poor  efﬁciency,  high  risk
of  collateral  damage  and  limited  scientiﬁc  basis.20
Functional  stereotaxic  neurosurgery  was  born  in  the  ﬁrst
third  of  the  twentieth  century,  due  to  the  lack  of  phar-
macological  treatment  for  functional  neurologic  diseases
such  as  movement  disorders,  epilepsy,  pain  and  psychiatric
diseases.  The  main  objective  of  this  general  neurosurgery
branch  was  to  perform  minimal  injuries,  in  speciﬁc  sites
(nucleus  or  tracts),  thus  achieving  equilibrium  of  neural
activity.  The  theories  of  James  Papez  and  the  contributions
of  Paul  Mac-Lean,  made  that  the  cingulum,  the  amygdala,
the  hypothalamus  and  the  thalamus  were  recognized  as
important  components  of  a  regulatory  system  for  emotions
and  instinctive  conduct,  hence,  being  adequate  sites  for  the
chirurgical  treatment  of  mental  disease.21 Nowadays,  the
following  neuronal  structures  are  identiﬁed  as  chirurgical
sites  for  the  treatment  of  psychiatric  diseases:  the  anterior
cingulum,  the  subcaudate  tract,  the  anterior  limb  of  the
internal  capsule,  the  hypothalamus,  the  mammillary  bodies,
the  fornix,  the  subgenual  region,  the  accumbens  nucleus,
the  amygdala  and  the  subthalamic  nucleus.22
In  1954,  the  pharmaceutical  company  Smith,  Kline
&  French  received  the  approbation  by  the  Food  and
Drugs  Administration  for  the  use  of  antipsychotic  drug
denominated  chlorpromazine.19 By  the  end  of  1954,  the
chlorpromazine  had  already  been  administrated  in  more
than  2,000,000  mentally  ill  patients  in  the  United  States,
establishing  with  it  the  premise  that  ‘‘drugs  were  effective
and  safer  that  psychosurgery’’,  bringing  an  end  to  the  ﬁrst
stage  of  psychosurgery.23
Psychosurgery  still  produces  fear  in  many  countries  for
it  is  considered  it  could  be  used  as  a  mean  of  politi-
cal  or  social  control.24 Despite  the  severe  restrictions  and
public  denounces,  psychosurgery  continued  and  continues
being  performed  restrictively  in  the  United  States.  On  the
other  hand,  countries  like  Mexico,  Brazil,  Finland,  Sweden,
England,  Spain,  India,  Italy,  Germany  and  Belgium  allow  the
performing  of  these  procedures  with  humanitarian  purposes.
Psychiatric  neurosurgery  is  prohibited  in  Japan,  France,  El
Salvador  and  Australia.
Non  stereotaxic  psychiatric  neurosurgery  from  the  ﬁrst
half  of  the  twentieth  century  was  characterized  for  being
unspeciﬁc,  highly  invasive  and  mutilating,  performed  with
the  use  of  craniotomies,  frontal  and  temporal  lobectomies
and,  more  reﬁned,  front-thalamic  leucotomy  by  trepans  and
by  trans-orbital  via.  On  the  second  half  of  the  twentieth  cen-
tury,  stereotaxic  psychiatric  neurosurgery  proved  to  be  very
precise  based  on  the  polar  or  cartesian  localization  (Fig.  1),
t
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eproducible  by  the  milimetrical  human  brain  atlas,  with  sci-
ntiﬁc  bases  using  well  deﬁned  physiological  concepts  and
erforming  proof  of  electric  stimulation  before  to  perform
 lesion  (conﬁrm  the  result  prior  to  use  thermo-coagulation
ith  radiofrequency).  Ablative  neurosurgery  is  less  known
nd  entails  humanitarian  purposes  when  applied  on  patients,
nder  the  bioethics  concept  of  the  less  damage  possible
o  improve  the  functional  result,  and  has  been  a  common
ractice  in  many  developed  and  undeveloped  countries.
Deep  brain  stimulation  has  (DBS)  has  been  an  efﬁcient
nd  save  alternative  for  the  treatment  of  chronic  neuro-
ogic  diseases  such  as  epilepsy,  Parkinson’s’  disease  and
europathic  pain  (Fig.  2).10 Since  2002  the  ﬁrst  informs
egarding  the  use  of  DBS  on  psychiatric  diseases  have  been
ublished,  more  concretely  in  respect  to  the  treatment  of
ayor  depression  disorder8,10,25 and  obsessive-compulsive
isorder.8,10--12,25 In  short  time,  other  psychiatric  disor-
ers  were  included  such  as  Tourette’s  syndrome,  violent
ehaviour,  nervous  anorexia,  addiction  to  substances  and
ther  neuropsychiatric  disorders  such  a  dementia.9,10,25--27
he  main  advantage  of  DBS  lies  on  the  possibility  to  ‘‘module
he  brain  function’’  in  such  a  way  that  it  leads  to  the  desired
linical  effect  and  avoid  collateral  effects;  its  action  mech-
nism  different  from  the  stereotaxic  selective  lesion  allows
he  possibility  to  liberate  a  dose  of  electric  current  on
natomic  structures  very  circumscribed  using  a  combina-
ion  of  amplitude,  frequency  and  duration  of  the  electric
mpulse.25 The  main  disadvantage  of  DBS  is  the  cost  that
imits  in  almost  all  the  world  its  application  and  could  even
e  considered  an  ethical  dilemma.
Despite  the  increase  of  scientiﬁc  papers  discussing  this
ubject,  the  present  evidence,  even  for  the  mayor  series,  is
till  incipient  and  DBS  for  this  kind  of  disorders  is  still  consid-
red  an  experimental  treatment.  Additionally,  the  number
f  randomized  and  masked  clinical  essays  designed  for  DBS
n  mental  disorders  is  small.  This  is  justiﬁed  because  propos-
ng  a  ‘‘placebo’’  manoeuvre  over  a  neurosurgical  procedure
ould  be  ethically  questionable.  However  than  DBS  offers
he  possibility  to  effectuate  clinical  trial  with  a  ‘‘sham’’
rm,  if  it  is  consented  to  the  individual  subjected  to  the
tudy  to  be  included  randomly  on  a  transitory  period  with-
ut  electric  stimulation  to  later  be  subjected  to  DBS  therapy.
n  any  case,  the  increasing  interest  in  this  area  of  neu-
osciences  has  encouraged  the  establishment  of  speciﬁc
thical  guides.  The  more  broadly  diffused  is  the  one  pub-
ished  on  2009  by  Rabins  et  al.  In  it  speciﬁc  aspects  are  taken
nto  account,  such  as  considering  all  scientiﬁc  evidence
reclinical  and  clinical  before  performing  a  new  research
roject  with  DBS,  not  forgetting  the  historical  experience
egarding  the  unmeasured  and  uncontrolled  use  of  this  ther-
py,  establishing  very  specialized  and  interdisciplinary  work
eams,  assuring  the  wellbeing  of  the  research  subjects  not
nly  in  their  clinical  conditions  but  also  in  their  wellbeing
nd  quality  of  life,  establishing  a  sustainability  program  of
he  DBS  therapy  that  assures  the  patients  the  possibility  to
ontinue  with  their  treatment  specially  when  this  has  had
 beneﬁcial  effect,  maintaining  supervision  over  the  work
roups  of  the  local  ethical  committees  on  research  to  ensure
he  observance  of  research  subjects  rights  and  continuing
linical  studies  with  more  evidence  regarding  the  effects
nd  action  mechanisms  of  DBS.28
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Figure  1  In  this  picture  on  left  side  it  is  showing  a  stereotactic  procedure.  The  head  of  patient  is  ﬁxed  inside  of  Cartesian
coordinates system  (X:  red,  Y:  black,  Z:  white)  in  order  to  localize  a  speciﬁc  target  through  a  burr  hole  in  the  skull.  Prior  the
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Foordinates were  found  out  by  software  that  analyzed  magnet
nto basal  ganglia  (yellow  arrows).
Schermer  in  2011  published  than  DBS  practice  is  struc-
ured  in  the  four  basic  principles  of  medical  ethic:  (1)
on-maleﬁcence,  ‘‘ﬁrst  do  no  harm’’  (to  calculate  risk,
hysical  and  psychical  side  effects,  to  avoid  personal-
ty  changes  or  developing  brain).  (2)  Beneﬁcence,  ‘‘do
ell’’  (effectiveness  and  need  of  psycho-social  cares),  (3)
roportionality  and  subsidiarity,  ‘‘risks  and  beneﬁts  in  pro-
ortion,’’  ‘‘choose  least  burdensome  alternative?’’  and
‘refractory  to  others  treatments’’, (4)  Justice,  ‘‘treat
ike  cases  alike’’  respect  patients’  well-informed  choices’’
rationing  and  prioritizing,  inform  consent,  avoid  despera-
ion  and  unrealistic  expectation,  competence  to  consent  and
pecial  evaluation  in  minors).29
The  aim  of  this  review  was  to  analyzed  the  ethical  and
egulatory  aspects  of  psychiatric  neurosurgery.
ethod and material
or  this  review  the  authors  made  a  bibliographic  research
ooking  up  non-mesh  combination  terms:  ethical  issue
ND  psychosurgery;  ethical  issue  AND  psychiatric  neu-
osurgery;  ethical  considerations  AND  psychosurgery  and
thical  considerations  AND  psychiatric  neurosurgery.  Lim-
ts  were  English  or  Spanish  language,  10  years  prior  to
earching  (from  2005  to  2014),  abstract  available,  contain-
ng  statements  about  ethical  discussion  or  regulatory  issues
bout  psychosurgery.  Further  analysis  in  order  to  ﬁnd  papers
hared  in  different  searchers.  The  information  was  classiﬁed
o  present  ethical  discussion  for  speciﬁc  surgical  procedures,
thical  or  regulatory  aspects  and  ethical  dilemmas.  Exclu-
ion  criteria  were  containing  animal  model  information  or
nspeciﬁc  conclusion.esults
nitially,  this  searching  strategy  allowed  ﬁnding  77  studies.
9  papers  completed  inclusion  and  exclusion  criteria.
e
N
c
tsonance  and  CT-scan  images.  Right  side  shows  two  electrodes
our  articles  were  guide  or  regulatory  works.40--42
wenty-four  were  ethical  discussion18,38,43--65 and  9  ethical
ilemmas.46,66--74
More  important  essays  included:  Consensus  on  guidelines
or  stereotactic  neurosurgery  for  psychiatric  disorders,  pub-
ished  in  2014  where  is  commented  about  the  necessity
f  increase  the  level  of  evidence  and  design  randomized
linded  clinical  trials  in  order  to  get  information  of  abla-
ive  or  DBS  procedures.  Always  is  mandatory  to  observe  to
nhance  patient  safety.  Expert  committee  conducted  this
tudy.
Algorithm  of  study  and  treatment  of  this  kind  of  patients
as  proposed  in  Fig.  2.
iscussion
sychosurgery  has  many  aspects  to  be  analysed  from  the
ioethical  point  of  view.  One  of  these,  as  mentioned  before,
s  the  controversial  history  of  the  ﬁrst  half  of  the  twentieth
entury.  Psychosurgery  had  its  origin  in  a  moment  in  which
here  were  no  psychopharmaceutic  treatments  and  the  only
ption  to  treat  psychiatric  signs  was  surgery.  The  fact  that
n  operation  alleviated  the  psychiatric  symptoms  was  the
otif  that  gave  the  Nobel  Prize  to  Egas  Moniz  during  the  thir-
ies  and  both  society  and  the  scientiﬁc  community  validated
hese  therapeutic  procedures.  Yet,  despite  the  evident  lack
f  clear  indications  for  its  application,  the  beneﬁcial  results
ometimes  not  very  tangible  and  the  great  quantity  of  sec-
ndary  effect  of  psychiatric  neurosurgery  of  the  ﬁfties,  Dr.
reeman  was  convinced  that  what  he  was  doing  was  helping
atients  in  their  suffering,  always  acting  under  the  principle
hat  his  patient  could  improve.  However,  the  acting  of  Dr.
reeman  and  other  neurosurgeons  created  a  tension  in  soci-
ty  clearly  reﬂected  in  movies  like  One  Flew  Over  Cuckoo’s
ests.  Despite  scientiﬁc  data  of  the  beneﬁcial  effect  of  psy-
hosurgery  when  performed  speciﬁc  indications,  stereotaxic
echniques  and  radiofrequency,  the  social  pressure  made  the
The  role  of  bioethics  in  the  neurosurgical  treatment  of  psychiatr
Psychiatric diagnosis according to
DSMIV-R or DSM V
Abscence of neurological diagnosis
Including EEG and MRI or
Neurpsychological Battery
Chronical hystory of psychiatric
disorder (at least 5 years) for expert
psychiatrist
Supervised pharmacological treatment
including: Neuroleptics, anticonvulsant,
IRSS, benzodiazepine, beta-bloquers,
lithium and combinations.
Electroconvulsive therapy and
contention
Expert Psychosurgery Committee in
order to review selection criteria and
target
Inform Consent and /or Ethical
Committee
Surgical procedure into expert center
with adequate technological
instrumentation according to specific
protocol
At least 10 years of follow up for the
Expert Psychosurgical Committee
Figure  2  Algorithm  of  study  and  follow  up  of  patients
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mcandidates  to  psychosurgery.  IRSS  means  Inhibitors  re-uptake
selective  serotonine.
United  States  Congress  to  limit  the  use  of  psychosurgery,
thus,  for  a  few  decades,  only  some  areas  in  the  American
Union  allowed  these  procedures.  Something  similar  hap-
pened  in  other  countries.  In  Japan,  professor  Narabayashi
was  taken  out  from  the  back  door  of  the  hotel  in  which
he  presented  some  of  his  data,  for  a  crowd  nearly  lynched
him.  From  heaven,  by  receiving  the  Nobel  Prize,  to  hell,
with  limitations  that  almost  extinguished  the  procedure.
Two  events  provoked  the  stigmatization  of  psychosurgery:
The  rise  of  psychopharmaceutic,  which  allowed  the  control
of  the  symptomatology,  and  the  ethical  disdain  of  avoid-
ing  to  fall  in  the  hands  of  neurosurgeons  apparently  without
scruples.  Is  very  valid  to  make  a  reﬂexion  to  consider  the
real  ethical  dilemma  regarding  surgical  techniques  and  the
I
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hysiopathology  of  psychiatric  diseases  during  these  period.
nfortunately,  up  to  this  point  no  animal  model  will  sufﬁce
o  understand  the  physiopathology  of  every  human  mental
isorder.  In  consequence,  the  neurosurgical  treatment  of
sychiatric  disorders  was  and  will  be  many  times  extrap-
lated  from  the  experience  of  the  neurosurgeon  during  the
reatment  of  other  diseases  such  as  Parkinson’s,  dystonia  or
he  very  mental  disease.  Despite  the  possible  limitations  of
sychiatric  neurosurgery;  if  used  correctly  the  ethical  princi-
le  of  the  lesser  bad,  psychosurgery  was  and  is  preferable  to
aving  patients  in  which  no  concrete  therapy  can  be  offered
Table  1).
Another  aspect  to  analyse  is  the  one  implying  the
oexistence  of  relatives  with  a  psychiatric  patient  with-
ut  adequate  or  refractory  control.  The  practice  has
emonstrated  that  certain  aggressive  patients  with  mental
etardation  have  provoked  a  wear  syndrome  on  their  rela-
ives,  very  common  on  personal  working  in  chronical  and
sychiatric  hospitals.  Psychosurgery  has  diminished  auto  and
etero  aggression,  thus  preventing  injuries  to  the  patients
nd  others.  Every  time  a psychiatric  patient  is  proposed  for
 surgical  procedure  that  improves  their  psychiatric  symp-
oms,  its  case  must  be  presented  to  a  Hospital  Committee
f  Bioethics  or  to  a  Committee  of  Research  Ethics,  depend-
ng  on  the  case,  and  the  rights  and  wellbeing  of  the  patient
ust  be  evaluated  same  as  his  reinsertion  on  familiar,  social
nd,  if  possible,  working  life.
The  best  ethic  model  for  this  kind  of  problems  remains
unctually  projected  only  to  man.  The  great  advantages
f  DBS  in  comparison  with  stereotaxic  brain  lesions  has
roduced  a  very  important  resurgence  of  psychiatric  neu-
osurgery;  the  reversibility  of  the  effects  that  avoids  direct
amage  over  the  neurons  or  the  ﬁbbers,  the  adjustment  of
lectric  parameters  by  telemetry  from  the  outside  with-
ut  need  of  invasion  to  the  patient  with  the  exception  of
lacing  the  system  and  the  versatility  regarding  the  stim-
lation  programs,  make  the  new  implantable  systems  able
o  help  patients.  Yet  again  the  counterpart  of  disadvantages
merges,  which  could  become  real  ethical  dilemmas:  an  DBS
ystem  is  very  expensive,  with  costs  that  go  from  17  to  33
housand  dollars  only  for  the  equipment,  adding  the  cost  of
edical  assistance  and  follow  up.
Which  psychiatric  patients  can  be  candidates  to  this  type
f  treatment?  In  the  case  that  this  could  be  consider  a
herapeutic  alternative  in  state  of  art  and  not  only  an  exper-
mental  alternative:  Could  systems  of  a  social  or  private
ecurity  accept  that  psychiatric  disorders  are  a  valid  sur-
ical  indication?  There  are  some  research  projects,  like  in
he  case  of  Tourette’s  syndrome,  where  four  stimulators  in
ifferent  targets  have  been  placed,  which  complicates  con-
iderably  their  use.  Additionally,  the  lifespan  of  the  pulse
enerator  or  battery  is  very  limited  and  can  vary,  because
epending  on  the  clinical  improvement  is  how  the  parame-
ers  are  adjusted,  mainly  in  amplitude.  It  has  been  reported
hat  batteries  can  last  from  one  to  six  years  before  a  change
s  needed;  therefore  their  replacement  will  be  limited  to
 good  medical  expenses  insurance  that  covers  said  equip-
ent,  or  else,  to  the  existence  of  donations  to  the  matter.t  is  also  needed  a  good  expert  medical  team  in  the  area  to
onitor  the  patient.
Another  important  bioethical  question  emerges,  one
spect  is  to  diminish  the  psychiatric  symptoms  and  another  is
52  F.  Jiménez-Ponce  et  al.
Table  1  This  table  shows  main  targets  and  their  indications  for  psychiatric  disorders  by  original  authors.
Author  Indication  Anatomic
structure
Year  Improvement  Side  effects
Gabriëls30 OCD  IC  2003  44--59%  None
Sturm31 OCD  NAc  2003  Signiﬁcant  None
Jiménez32,33 MDD/OCD  ITP  2005/2009  100/50%  Anxiety
Mayberg34 MDD  Area25  2005  Sustained  remission  None
Visser-Vandewalle35 Tourette  InLThN  2006  Signiﬁcant  Hypomania
Mallet36 OCD  STN  2008  32%  Edema,  bleeding
and  infection
Kuhn26,27 Addiction
alcohol/tobacco
NAc  2007/2009  100/20.30%  None
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RWu37 Anorexia  NAc  
o  modify  thoughts  and  feelings  of  the  patient.  This  aspect
s  more  tangible.  One  thing  is  to  manipulate  only  neuro-
hysiologic  sensitivity  and  motor  skills,  and  another  is  to
odify  cognition  or  will.  In  the  case  that  a  depressed  patient
hat  has  had  various  suicidal  attempts  DBS  seems  to  be  jus-
iﬁed.  In  a  patient  with  obsessive  compulsive  behaviours
he  actual  evidence  seems  to  prove  that  its  functionality
epends  on  the  implantation  and  the  equipment  effect,
gain  psychosurgery  seems  justiﬁed.
Koivuniemi  and  Otto  published  this  year  a  paper  that  dis-
usses  the  meaning  of  ‘‘Mind  Control’’  in  the  context  of  DBS.
hey  postulate  three  conditions  that  can  clearly  deﬁne  what
n  the  context  DBS  would  mind  control  mean:  The  criteria  of
esults  that  implies  an  objective  change  in  the  behaviour  of
he  stimulated  subject,  the  criteria  of  approval  which  means
hat  the  subject  in  question  has  not  manifested  its  approval
or  the  DBS  to  modify  his  behaviour  and  the  third  criteria
ould  be  of  intention,  this  means  that  the  researcher  man-
fests  that  he  intentionally  looked  for  that  change  in  the
ehaviour.38 These  three  criteria  have  not  been  present  in
ny  case  up  to  now.  However,  in  the  case  of  the  patients  that
annot  manifest  their  approval  for  the  change  of  behaviour
ike  in  patients  in  vegetative  state  where  Yamamoto  has
timulated  the  thalamus  to  improve  their  vigilance  state,
r  in  cases  in  which  the  researcher  ﬁnds  a  collateral  effect
hat  could  be  beneﬁcial  yet  not  the  one  desired  (in  2007
hun  tried  to  diminish  the  anxiety  of  an  alcoholic  patient
timulating  the  accumbens  nucleus  and  what  he  obtained
as  a  diminishment  in  the  desire  to  consume  alcohol).27 On
hese  cases  if  the  researcher  does  not  informs  the  patient,
nce  observed  the  unexpected  effect,  we  could  talk  about
ind  control.
Yet,  this  type  of  therapy  opens  the  door  to  other  col-
ateral  aspects.  Is  it  ethic  or  moral  the  neuromodulation
n  order  to  increase  the  executive  capacities  not  only  of
atients  but  also  from  sane  subjects?  This  aspect  of  DBS  is
enominated  ‘‘enhancement’’.  Is  it  licit  to  use  certain  brain
reas  to  manipulate  behaviours,  which  could  be  the  case  of
lacing  electrodes  in  the  amygdala  and  by  stimulating  this
rea  favouring  braver  soldiers  during  battle?  Could  a  modu-
ation  be  placed  that  makes  a  person  submissive?  There  is  a
hole  bioethical  discussion  that  can  barely  be  seen.39
The  purpose  of  bioethics  is  to  encourage  the  reﬂexion
n  which  individuals  understand  that  the  most  important  is
he  respect  and  dignity  of  people.  Some  years  ago  it  was13  85%  None
nthinkable  that  through  an  electrode  thoughts  could  be
odiﬁed,  nowadays,  this  is  a  reality.  Is  technology  bad?
o;  technology  is  nor  good  nor  evil,  it  depends  on  how  it
s  used  and  who  uses  it  to  make  man  complement  what  is
ore  important  as  a  prerogative  after  life,  which  is  his  free-
om.  However,  in  the  case  of  psychosurgery  is  fundamental
o  understand  that  many  of  these  patients  are  ‘‘tied’’  to  a
sychiatric  disease  that  undermines  their  consciousness  and
hus  limits  their  freedom.
Finally,  psychosurgery  opens  another  possibility:  trans-
umanism,  meaning,  the  colocation  of  prosthesis  or
ttachments  that  replace  lost  functions.  The  Cyborg  neol-
gism,  conceptualized  as  a  cybernetic  organism,  makes
llusion  to  this  fact.  When  a  patient  is  implanted  with  a
rain  electrode,  technology  that  tries  to  recover  a  function
hat  is  no  more  is  being  applied.  Here  could  enter  all  sci-
nce  ﬁction  literature  that  has  generated  in  the  last  ﬁfty
ear  regarding  human  being  that  have  become  half  robot
alf  human  beings.  The  bioethical  discussion  on  this  point  is
lso  very  important.
Psychosurgery  remain  been  a  medical,  social  and  philo-
ophical  challenge  that  must  not  forget  the  most  important
spect  which  is  the  comprehension  of  the  disease  and  the
bservance  of  the  subjects’  human  rights  per  se,  maxim  in
 psychiatric  patient.
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